The objective of the Trial of Antihypertensive Intervention Management (TAIM) was to
determine the efficacy of dietary management and/or drug therapy, namely thiazide-like
diuretics or a beta-blocker, in the control of mild hypertension. Additionally, the
Continuation of the Trial of Antihypertensive Intervention Management (COTAIM) tested the
effects of long-term weight reduction, and sodium/potassium changes added to weight
reduction, as well as the original drug treatment, on the failure rate of blood pressure
control.
Systolic Hypertension in the Elderly Program (SHEP)
Completed
National Institute on Aging (NIA)
Phase 3
1984-06-01
The primary objective was to assess whether long-term administration of antihypertensive
therapy to elderly subjects with isolated systolic hypertension reduced the combined
incidence of fatal and non-fatal stroke. The secondary objectives were to evaluate: the
effect of long-term antihypertensive therapy on mortality from any cause in elderly people
with isolated systolic hypertension; possible adverse effects of chronic use of
antihypertensive drug treatment in this population; the effect of therapy on indices of
quality-of-life; the natural history of isolated systolic hypertension in the placebo
population.
Systolic Hypertension in the Elderly Program (SHEP)
Completed
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3
1984-06-01
The primary objective was to assess whether long-term administration of antihypertensive
therapy to elderly subjects with isolated systolic hypertension reduced the combined
incidence of fatal and non-fatal stroke. The secondary objectives were to evaluate: the
effect of long-term antihypertensive therapy on mortality from any cause in elderly people
with isolated systolic hypertension; possible adverse effects of chronic use of
antihypertensive drug treatment in this population; the effect of therapy on indices of
quality-of-life; the natural history of isolated systolic hypertension in the placebo
population.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
